6426 - 6450 of 9038 Results
Title
Year
- Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian Syndrome2025RESTRICTEDTitle: Diagnostic Value of Swallow Tail Sign at Brain MRI in Patients with Clinically Uncertain Parkinsonian SyndromeJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 316Issue #: 1Start Page: e240680End Page: e240680Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1148/radiol.240680Citation Count: 3
-
OPENTitle: Generation of two induced pluripotent stem cell lines and the corresponding isogenic controls from Parkinson’s disease patients carrying the heterozygous mutations c.1290A > G (p.T351A) or c.2067A > G (p.T610A) in the RHOT1 gene encoding Miro1Journal Name: Stem Cell ResearchPublisher: Elsevier BVVol: 69Issue #:Start Page: 103085End Page: 103085Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.scr.2023.103085Best OA location URL: https://doi.org/10.1016/j.scr.2023.103085Citation Count: 3
- How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?2020RESTRICTEDTitle: How specific are non-motor symptoms in the prodrome of Parkinson's disease compared to other movement disorders?Journal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 81Issue #:Start Page: 213End Page: 218Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.10.003Citation Count: 19
-
OPENTitle: α-Synuclein-induced dopaminergic neurodegeneration in a rat model of Parkinson's disease occurs independent of ATP13A2 (PARK9)Journal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 73Issue #:Start Page: 229End Page: 243Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.nbd.2014.10.007Best OA location URL: https://doaj.org/article/cf729f11ec754abb83db0191be6da9cfCitation Count: 45
-
OPENTitle: New insights from a Malaysian real-world deep brain stimulation cohortJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 15Issue #: 1Start Page: 189End Page: 201Publication Date:Open Access(OA) Status: OPENLicense: cc-by-ncDOI - Digital Object Identifier: 10.1177/1877718x241297715Best OA location URL: https://doi.org/10.1177/1877718x241297715Citation Count: 4
-
OPENTitle: Disease progression models for dominantly-inherited Alzheimer’s diseaseJournal Name: BrainPublisher: Oxford University Press (OUP)Vol: 141Issue #: 5Start Page: 1244End Page: 1246Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1093/brain/awy089Best OA location URL: https://academic.oup.com/brain/article-pdf/141/5/1244/25083196/awy089.pdfCitation Count: 3
-
OPENTitle: Alpha‐Synuclein Oligomers and Neurofilament Light Chain in Spinal Fluid Differentiate Multiple System Atrophy from Lewy Body SynucleinopathiesJournal Name: Annals of NeurologyPublisher: WileyVol: 88Issue #: 3Start Page: 503End Page: 512Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/ana.25824Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/7719613Citation Count: 127
- High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia Nigra2019RESTRICTEDTitle: High-Spatial-Resolution Diffusion MRI in Parkinson Disease: Lateral Asymmetry of the Substantia NigraJournal Name: RadiologyPublisher: Radiological Society of North America (RSNA)Vol: 291Issue #: 1Start Page: 149End Page: 157Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1148/radiol.2019181042Citation Count: 55
- Tissue engineered nigrostriatal pathway for treatment of Parkinson's disease2018RESTRICTEDTitle: Tissue engineered nigrostriatal pathway for treatment of Parkinson's diseaseJournal Name: Journal of Tissue Engineering and Regenerative MedicinePublisher: WileyVol: 12Issue #: 7Start Page: 1702End Page: 1716Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1002/term.2698Citation Count: 63
-
OPENTitle: TMEM175, SCARB2 and CTSB associations with Parkinson’s disease risk across populationsJournal Name: npj Parkinson's DiseasePublisher: Springer Science and Business Media LLCVol: 11Issue #: 1Start Page: 348End Page: 348Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41531-025-01180-zBest OA location URL: https://www.nature.com/articles/s41531-025-01180-z_reference.pdfCitation Count: 4
-
OPENTitle: Discordance Between Balance Ability and Perception Is Associated With Falls in Parkinson’s Disease: A Coordinated AnalysisJournal Name: Neurorehabilitation and Neural RepairPublisher: SAGE PublicationsVol: 39Issue #: 2Start Page: 114End Page: 125Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1177/15459683241300456Best OA location URL: https://pmc.ncbi.nlm.nih.gov/articles/PMC11850210/pdf/nihms-2033435.pdfCitation Count: 9
- Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease Onset2020OPENTitle: Common Variants Coregulate Expression of GBA and Modifier Genes to Delay Parkinson's Disease OnsetJournal Name: Movement DisordersPublisher: WileyVol: 35Issue #: 8Start Page: 1346End Page: 1356Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mds.28144Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mds.28144Citation Count: 40
- Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s Disease2016OPENTitle: Patient Perspectives on Deep Brain Stimulation Clinical Research in Early Stage Parkinson’s DiseaseJournal Name: Journal of Parkinson’s DiseasePublisher: SAGE PublicationsVol: 7Issue #: 1Start Page: 89End Page: 94Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.3233/jpd-161031Citation Count: 15
-
OPENTitle: Association Between Furosemide and Risk of Parkinson's Disease in a Nested Case–Control StudyJournal Name: Basic & Clinical Pharmacology & ToxicologyPublisher: WileyVol: 138Issue #: 6Start Page: e70249End Page: e70249Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/bcpt.70249Best OA location URL: https://doi.org/10.1111/bcpt.70249Citation Count: 0
- Detection of Proteolytic Signatures for Parkinson's Disease2016RESTRICTEDTitle: Detection of Proteolytic Signatures for Parkinson's DiseaseJournal Name: Future NeurologyPublisher: Informa UK LimitedVol: 11Issue #: 1Start Page: 15End Page: 32Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.2217/fnl.16.3Citation Count: 0
-
OPENTitle: GBA mutations in Parkinson disease: earlier death but similar neuropathological featuresJournal Name: European Journal of NeurologyPublisher: WileyVol: 24Issue #: 11Start Page: 1363End Page: 1368Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ene.13395Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5657539Citation Count: 34
-
OPENTitle: Plasma phosphorylated tau 217 and phosphorylated tau 181 as biomarkers in Alzheimer's disease and frontotemporal lobar degeneration: a retrospective diagnostic performance studyJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 9Start Page: 739End Page: 752Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00214-3Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/8711249Citation Count: 588
-
OPENTitle: The International Parkinson Disease Genomics Consortium AfricaJournal Name: The Lancet NeurologyPublisher: Elsevier BVVol: 20Issue #: 5Start Page: 335End Page: 335Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/s1474-4422(21)00100-9Best OA location URL: http://www.thelancet.com/article/S1474442221001009/pdfCitation Count: 27
- Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's disease2019RESTRICTEDTitle: Impact of oral COMT-inhibitors on gut microbiota and short chain fatty acids in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 70Issue #:Start Page: 20End Page: 22Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2019.11.020Citation Count: 19
-
OPENTitle: Parkinson's Disease Associated with G2019S LRRK2 Mutations without Lewy Body PathologyJournal Name: Movement Disorders Clinical PracticePublisher: WileyVol: 11Issue #: 7Start Page: 874End Page: 878Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mdc3.14068Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mdc3.14068Citation Count: 12
- NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in rat2015RESTRICTEDTitle: NLX-112, a novel 5-HT 1A receptor agonist for the treatment of l -DOPA-induced dyskinesia: Behavioral and neurochemical profile in ratJournal Name: Experimental NeurologyPublisher: Elsevier BVVol: 271Issue #:Start Page: 335End Page: 350Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.expneurol.2015.05.021Citation Count: 79
-
OPENTitle: Measures of impulsivity in Parkinson's disease decrease after DBS in the setting of stable dopamine therapyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 44Issue #:Start Page: 13End Page: 17Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2017.08.006Best OA location URL: http://www.prd-journal.com/article/S1353802017302870/pdfCitation Count: 26
-
OPENTitle: Improvement of dyskinesias withl-dopa infusion in advanced Parkinson's diseaseJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 133Issue #: 6Start Page: 451End Page: 458Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/ane.12483Best OA location URL: http://www.scopus.com/inward/record.url?scp=84941312569&partnerID=8YFLogxKCitation Count: 27
-
OPENTitle: Pre-clinical therapeutic development of a series of metalloporphyrins for Parkinson's diseaseJournal Name: Toxicology and Applied PharmacologyPublisher: Elsevier BVVol: 326Issue #:Start Page: 34End Page: 42Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.taap.2017.04.004Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/5704913Citation Count: 14
-
OPENTitle: Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p. A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative StudyJournal Name: Movement DisordersPublisher: WileyVol:Issue #:Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.70236Best OA location URL: https://doi.org/10.1002/mds.70236Citation Count: 0